Keywords: sumitomo, granted, yuhan, rights, market, meropenem, pharmaceuticals

Sumitomo has granted Yuhan rights to market meropenem

Article | 31 July 1995

- Sumitomo Pharmaceuticals has granted South Korean company Yuhan Corp exclusive rights to manufacture and market Sumitomo's carbapenem antibiotic meropenem in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Meropenem

Merrem I.V.

Indocin

Indomethacin

Go to drug listing